By expenditures
| Name | Title | Type |
|---|---|---|
| Jenny Singh | Finance Officer | Auditee |
| Ryan Engebretson | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 370766 | 2024 | 2025-10-14 | Cliftonlarsonallen LLP | $5.93M |
| 319561 | 2023 | 2024-09-13 | Cliftonlarsonallen LLP | $6.40M |
| 47032 | 2022 | 2023-08-27 | Cliftonlarsonallen LLP | $6.01M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 319561 | 2023 | 2024-09-13 | 1073283 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 1073282 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 1073281 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 1073280 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 496841 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 496840 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 496839 | 2023-002 | Significant Deficiency | - | I |
| 319561 | 2023 | 2024-09-13 | 496838 | 2023-002 | Significant Deficiency | - | I |
| 47032 | 2022 | 2023-08-27 | 627375 | 2022-003 | Significant Deficiency | Yes | I |
| 47032 | 2022 | 2023-08-27 | 627374 | 2022-002 | Significant Deficiency | - | AB |
| 47032 | 2022 | 2023-08-27 | 627373 | 2022-003 | Significant Deficiency | Yes | I |
| 47032 | 2022 | 2023-08-27 | 627372 | 2022-002 | Significant Deficiency | - | AB |
| 47032 | 2022 | 2023-08-27 | 627371 | 2022-003 | Significant Deficiency | Yes | I |
| 47032 | 2022 | 2023-08-27 | 627370 | 2022-002 | Significant Deficiency | - | AB |
| 47032 | 2022 | 2023-08-27 | 50933 | 2022-003 | Significant Deficiency | Yes | I |
| 47032 | 2022 | 2023-08-27 | 50932 | 2022-002 | Significant Deficiency | - | AB |
| 47032 | 2022 | 2023-08-27 | 50931 | 2022-003 | Significant Deficiency | Yes | I |
| 47032 | 2022 | 2023-08-27 | 50930 | 2022-002 | Significant Deficiency | - | AB |
| 47032 | 2022 | 2023-08-27 | 50929 | 2022-003 | Significant Deficiency | Yes | I |
| 47032 | 2022 | 2023-08-27 | 50928 | 2022-002 | Significant Deficiency | - | AB |